[EN] QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS<br/>[FR] ANALOGUES DE QUINUCLIDINONE UTILISÉS EN TANT QU'AGENTS ANTICANCÉREUX
申请人:NEWAVE PHARMACEUTICAL INC
公开号:WO2021158948A1
公开(公告)日:2021-08-12
The disclosure includes compounds of Formula (I) and Formula(A) wherein R1, R2, R3, m, n, k, and L are defined herein. Also disclosed are methods for treating a neoplastic disease, autoimmune disease, or an inflammatory disorder with these compounds.
该披露包括式(I)和式(A)的化合物,其中R1、R2、R3、m、n、k和L在此处被定义。还披露了使用这些化合物治疗恶性肿瘤疾病、自身免疫疾病或炎症性疾病的方法。